Inhibitory Effect of Simvastatin on Insulin Secretion from Pancreatic Islet Beta-Cells in Rats
Bao-cheng CHANG,Chun-yan SHAN,Miao-yan ZHENG,Hui-zhu REN,Bai CHANG,Li-ming CHEN,Pei-hua FANG
DOI: https://doi.org/10.3760/cma.j.issn.1674-5809.2010.06.012
2010-01-01
Abstract:Objective To evaluate the inhibitory effect of simvastatin on glucose-stimulated insulin secretion (GSIS) and its mechanisms from pancreatic islet beta-cells in rats. Methods Eight-week-old male Wistar rats weighing 250 to 300 g were fed in a specific pathogen-free laboratory and killed within 1 week to isolate pancreatic islets. According to the average volume, freshly isolated or 24-hour cultured pancreatic islets were divided into the control group(incubated with Kreb-Ringer bicarbonate buffer, n=60) and the simvastatin group(incubated with 100 μmol/L simvastatin, n=60). Stimulated by 2.8, 5.5, 11.1, 16.7 and 25.0 mmol/L glucose respectively, the effect of 100 μmol/L simvastatin on ATP content and GSIS was compared in the two groups. GSIS was performed by the 37 ℃ batch incubation method and ATP content was measured by chemiluminescence method. t test was used for data analysis. Results Incubated with 100 μmol/L simvastatin for 30 minutes, in the presence of 25 mmol/L glucose, the ATP content was significantly reduced in comparison with the control group ((9.2±1.6) vs (12.1±1.9) pmol/islet, t=2.97, P 30 μmol/L, simvastatin showed a dose-dependent suppression in GSIS (2.49±0.21 vs 3.17±0.23, t=2.445, P<0.05). Conclusion At a higher concentration, simvastatin may inhibit GSIS by decreasing ATP content in pancreatic islet beta-cells. Key words: Islets; ATP; Simvastatin